Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice
Open Access
- 28 November 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (23) , 16858
Abstract
We have previously shown that an excess of deoxycorticosterone acetate and high sodium chloride intake (DOCA/salt) in one-renin gene mice induces a high urinary Na/K ratio, hypokalemia, and cardiac and renal hypertrophy in the absence of hypertension. Dietary potassium supplementation prevents DOCA/salt-induced pathological processes. In the present study, we further study whether DOCA/salt-treated mice progressively develop chronic inflammation and fibrosis in the kidney and whether dietary potassium supplementation can reduce the DOCA/salt-induced renal pathological process. Results showed that (1) long-term DOCA/salt-treated one-renin gene mice developed severe kidney injuries including tubular/vascular hypertrophy, mesangial/interstitial/perivascular fibrosis, inflammation (lymphocyte’s immigration), proteinuria, and high serum creatinine in the absence of hypertension; (2) there were over-expressed mRNAs of plasminogen activator inhibitor-1 (PAI-1), fibronectin, collagen type I and III, interferon-inducible protein-10 (IP-10), monocyte chemotactic protein-1 (MCP1), transforming growth factor-β (TGF-β), tumor necrosis factor-alpha (TNF-α), osteopontin, Nuclear factor kappa B (NF-κB)/P65, and intercellular adhesion molecule (ICAM)-1; and (3) dietary potassium supplementation normalized urinary Na/K ratio, hypokalemia, proteinuria, and serum creatinine, reduced renal hypertrophy, inflammations, and fibrosis, and down-regulated mRNA expression of fibronectin, Col-I and III, TGF-β, TNF-α, osteopontin, and ICAM without changes in the blood pressure. The results provide new evidence that potassium and sodium may modulate proinflammatory and fibrotic genes, leading to chronic renal lesions independent of blood pressure.Keywords
Funding Information
- Research of Nephrology CHUV (28515 Q.W.)
This publication has 32 references indexed in Scilit:
- Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- The role of osteopontin in inflammatory processesJournal of Cell Communication and Signaling, 2009
- Fibronectin Expression Modulates Mammary Epithelial Cell Proliferation during Acinar DifferentiationCancer Research, 2008
- Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin IIKidney International, 2008
- Hypokalemic Nephropathy is Associated with Impaired AngiogenesisJournal of the American Society of Nephrology, 2008
- Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7American Journal of Physiology-Renal Physiology, 2007
- Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentrationCell Death & Differentiation, 2007
- The role of TNF-α in diabetic nephropathy: Pathogenic and therapeutic implicationsCytokine & Growth Factor Reviews, 2006
- Potassium Supplementation Reduces Cardiac and Renal Hypertrophy Independent of Blood Pressure in DOCA/Salt MiceHypertension, 2005
- Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young ratsKidney International, 2001